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Abstract
Background: Neuroacanthocytosis (NA) syndromes are a group of rare diseases characterized by the presence of acanthocytes and neuronal multisystem
pathology, including chorea-acanthocytosis (ChAc), McLeod syndrome (MLS), Huntington’s disease-like 2 (HDL-2), and pantothenate kinase-associated
neurodegeneration (PKAN). China has the largest population in the world, which makes it a good location for investigating rare diseases like NA.
Methods: We searched Medline, ISI Proceedings, China National Knowledge Infrastructure, and Wanfang Data for literature published through December 31,
2013 for all the published Chinese NA case reports and extracted the clinical and laboratory findings.
Results: A total of 42 studies describing 66 cases were found to be eligible for inclusion. Age of symptom onset ranged from 5 to 74 years. The most common
findings included hyperkinetic movements (88%), orofacial dyskinesia (80%), dystonia (67%), and dysarthria (68%), as well as caudate atrophy or enlarged lateral
ventricles on neuroimaging (64%), and elevated creatine kinase (52%). Most cases were not confirmed by any specific molecular tests. Only two cases were
genetically studied and diagnosed as ChAc or MLS.
Discussion: In view of the prevalence of NA syndromes in other countries, the number of patients in China appears to be underestimated. Chinese NA patients
may benefit from the establishment of networks that offer specific diagnoses and care for rare diseases.
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Introduction
Neuroacanthocytosis (NA), an umbrella term for a group of rare
diseases characterized by misshapen erythrocytes (acanthocytes) and
neuronal multisystem pathology, includes diseases such as autosomal
recessive chorea-acanthocytosis (ChAc), X-linked McLeod syndrome
(MLS), Huntington’s disease-like 2 (HDL-2), and pantothenate kinase-
associated neurodegeneration (PKAN).1 NA was first described as
Levine-Critchley syndrome on the basis of reports by Levine and
Critchley in two families from North America in the 1960s.2,3 Although
the clinical manifestations of NA resemble Huntington’s disease (HD),
there are clear differences in the mode of inheritance and neuropatho-
logical changes. In the last decade, molecular and protein methods have
rapidly developed for the diagnosis of different NA subtypes.
China has the largest population in the world (1.35 billion), making
it a suitable location for investigating rare diseases like NA. The first
Chinese NA literature is a translation of the paper by Sakai et al in
1981.4,5 Over the last 30 years, few Chinese NA case reports have been
published.6–53 Moreover, communication with foreign scholars was
limited because most of the reports were published in Chinese. ChAc
has been reported in many different ethnic groups, and the relatively
high prevalence in Japan appears to be due to a founder mutation.54 In
light of the similar East Asian backgrounds in the two countries, we
suspect that in China NA syndromes are underdiagnosed, leading to a
significant underestimation of the prevalence.
In the current study, we systematically reviewed Chinese NA
epidemiology by searching for published NA cases. We aimed to
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6 Anhui 1984 2 2M 19, 27 Orof. (1), MD/Orof.
(1)
23%, 3% ChAc
7 Anhui 1987 2 2M 26, 32 DYA (1), MD/Orof.
(1)
10% ChAc
8 Anhui 2000 2 2F 45, 46 MD (1), PSY (1) 35%, 17% ChAc
9 Anhui 2004 1 1M 39 Orof./MD 4–7% ChAc
10 Beijing 2005 1 1F n.a. MD 4% ChAc
11–
14
Beijing 2005, 2012 8 2M,
6F
10–35 Orof. (4), MD (3), PN
(1)
.10% NA
15 Beijing 2007 2 2M 27, 37 MD (1), EPI (1) 15–25% ChAc
16 Beijing 2010 1 1M 11 n.a. 30% NA
17,
18
Beijing 2013 1 1M 42 MD/Orof. .40% NA NBIA
19 Beijing 2013 3 3M 16–43 MD, Orof. (2), BP (1) .30% NA
20 Chongqing 2013 1 1F 33 DYA/WI/MD/Orof. .3% ChAc
21 Gansu 2009 1 1M 20 MD n.a. NA
22 Guangdong 2003 1 1M 42 Orof. 30% ChAc
23 Helongjiang 1989 1 1F 36 DYA/Orof. 15–20% ChAc
24 Helongjiang 1989 2 1M,
1F
9, 11 Orof. 56%, 28% ChAc NBIA
25 Helongjiang 1990 1 1F 38 Orof. 40–50% ChAc
26,
27
Helongjiang 2003, 2007 1 1F 35 Orof. 28.5% ChAc
28 He’nan 2005 1 1F 30 Orof./EPI 25% NA
29 He’nan 2011 2 1M,
1F
30, 31 MD (1), Orof. (1) 35%, 25% ChAc
30 He’nan 2012 1 1M 43 MD 11%–15% ChAc
31 Hong Kong 2013 1 1M 47 GD/MD 16% MLS*
32 Hubei 2007 1 1F 28 Orof. 6–8% NA
33 Hubei 2013 1 1M 37 n.a. n.a. NA
34 Hu’nan 2013 1 1F 24 n.a. n.a. ChAc*
35 Jiangsu 2012 1 1F 20 MD/Orof. 7.8% ChAc
36 Liaoning 1989 1 1M 28 Orof. 84% ChAc
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summarize the features of Chinese NA cases in comparison with other
countries and identify potential reasons for underestimation.
Methods
We searched Medline (from January 1, 1949 to December 31,
2013), ISI Proceedings (January 1, 1990 to December 31, 2013), China
National Knowledge Infrastructure (http://www.cnki.net, from
January 1, 1979 to December 31, 2013) and Wanfang Data (http://
www.wanfangdata.com.cn, from January 1, 1984 to December 31,
2013). The search terms in English and their Chinese equivalents
included ‘‘neuroacanthocytosis,’’ ‘‘chorea-acanthocytosis,’’ ‘‘McLeod
syndrome,’’ ‘‘choreoacanthocytosis,’’ ‘‘hereditary acanthocytosis syn-
drome,’’ and ‘‘Levine-Critchley syndrome.’’ We also tried to identify
cases from cross-references between papers. We only included those
case reports where an explicit diagnosis of NA had been made by the
original authors. For inclusion, patients had to be of Chinese origin and
diagnosed in China. We extracted information on geographical origin,
sex, age of onset, and clinical and laboratory findings from each case.
Results
We identified a total of 48 publications with 66 cases reported (37
males and 29 females) (Table 1). All of these patients had been
diagnosed with NA, ChAc, or MLS by the reporting physicians. Only
one ChAc case was confirmed by a genetic test (VPS13A gene), and no
cases were confirmed by Western blot for the protein chorein that is
affected in ChAc.55 An elevated proportion of acanthocytes in blood
samples was regarded as the most important diagnostic clue by















37 Neimenggu 2005 1 1M 32 EPI 10% ChAc
38 Neimenggu 2007 1 1M 34 MD 10% ChAc
39 Neimenggu 2012 1 1M 38 Orof. 5% ChAc
40 Qinghai 2006 1 1F 24 MD 18% NA
41 Shandong 2001 3 3F 20–21 MD 12% NA
42 Shandong 2013 1 1M 32 MD/Orof. 10% ChAc
43 Shandong 2013 3 2M,
1F
26–50 MD/Orof. (1), PSY (2) .30% ChAc
44 Shanghai 2008 1 1F 33 MD/Orof. 7–8% ChAc
45 Shanghai 2008 1 1M 5 DYT .30% NA NBIA
46 Shanghai 2010 1 1F 55 WI .20% NA
47 Shanghai 2012 3 2M,
1F
31–74 MD (1), GD (2) 10–28% NA
48 Shanghai 2013 1 1M 46 WI, DYA 44.9% NA
49,
50
Shanxi 2004 3 2M,
1F
26–30 EPI (2), Orof. (1) 12–30% ChAc
51 Sichuan 2012 2 2M 17, 18 Orof. (2) 6%, 6% ChAc
52 Sichuan 1988 1 1M 25 Orof. 4% ChAc
53 Taiwan 2006 1 1F 31 MD 49% NA
Abbreviations: *, Gene Confirmed; AOO, Age of Onset; BP, Blepharospasm; ChAc, Chorea-Acanthocytosis; DYA, Dysarthria; DYT, Dystonia; EPI, Epilepsy; F, Female;
GD, Gait Disturbance; M, Male; MD, Movement Disorders (Chorea or Hyperkinetic Movements); MLS, McLeod Syndrome; n.a., Not Available; NA,
Neuroacanthocytosis; NBIA, Neurodegeneration with Brain Iron Accumulation (Type I/Type II); No., Number; Orof., Orofacial Dyskinesia; PN, Parkinsonism; PSY,
Psychiatric Symptoms; Ref., Reference; WI, Walking Instability.
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acanthocytosis were used in the different reports, thus affecting the
accuracy of the test. Only one MLS case, from Hong Kong, was
reported with a corresponding XK gene mutation.
In the most recent decade (2004 to 2013) the number of reported
cases increased dramatically, being about five times the number
documented from 1984 to 1993, and seven times the number
documented between 1994 and 2003 (Figure 1). No video recordings
were published with the publications reviewed in this study. With
respect to the geographic distribution, all cases originated from 19
Chinese provinces, with 16 cases reported in Beijing, 7 cases from
Anhui, and 7 cases from Shangdong as the top 3 provinces. The ages
of onset ranged from 5 to 74 years and were concentrated in the third
and fourth decades (n 5 37, 56%) (Figure 2). Common initial
symptoms were orofacial dyskinesia (n 5 27, 41%) and hyperkinetic
limb or trunk movements (n 5 27, 41%). Dysarthria, epilepsy, gait
disturbance, parkinsonism, and psychiatric symptoms were also
reported as the initial symptoms. Diagnoses were mainly made based
on the presence of a hyperkinetic movement disorder, elevated
acanthocytes in the blood, the pattern of inheritance (recessive), and
the exclusion of other possible diseases, such as HD.
Figure 3 summarizes the clinical and laboratory findings reported in
Chinese NA cases. The most frequent findings were hyperkinetic
movements (n 5 58, 88%). Orofacial dyskinesia was reported in 53
patients (80%). In addition, dystonia (n 5 44, 67%) and dysarthria (n
5 45, 68%) were also common. 10 patients (15%) suffered from
epilepsy, and 22 patients (33%) exhibited psychiatric symptoms.
With respect to clinical investigations, caudate atrophy or enlarged
lateral ventricles on neuroimaging (n 5 42, 64%) and elevated CK (n
5 34, 52%) were the most frequently reported.
Discussion
Hyperkinetic movements and orofacial dyskinesia were the most
common symptoms in this series of Chinese NA cases, reported in 88%
and 80% of patients, respectively. This is consistent with the literature
in that orofacial dyskinesia appears to be a relatively specific NA
symptom, characterized by tongue protrusion and feeding dystonia.
Chorea was typical in the early stages and tended to progress to
parkinsonism. Parkinsonism has occasionally been reported to be the
initial symptom.56,57
We found lower proportions of patients with epilepsy (15%) and
psychiatric symptoms (33%) than reported in the literature (50% and
66%, respectively).58,59
In our study, 52% of Chinese NA cases had elevated CK levels,
while only 11% of cases exhibited liver enzyme elevation, suggesting
that CK is probably a more useful biomarker for NA than
acanthocytes or liver enzymes, as is consistent with the literature.
However, values within normal ranges are likely to have been omitted
in many publications, thus, we could not accurately calculate the
proportion of patients with normal CK or liver enzyme levels.58
The number of cases reported for 1994–2003 is relatively low in
comparison to the numbers for 1984–1993 and 2004–2013. It is
possible that some cases were not reported because they were not
recognized or were not thought to be of interest after awareness was
originally raised regarding the syndrome. It is important to determine
whether these low rates of reported cases are due to publication bias
and incomplete documentation, or whether these discrepancies are
due to ethnic differences.
The clinical diagnosis of NA in China is mainly based on clinical
manifestations and an elevated proportion of acanthocytes in the
Figure 2. The Distribution of Ages of Onset in Chinese NA Cases.
Among the 63 cases with clearly documented ages of onset, most were
concentrated in the third and fourth decades (ages 21 to 40).
Figure 3. Clinical and Laboratory Findings in Chinese NA Patients
(n5 66). Abbreviations: CK, Creatine Kinase Elevation; IMG, Caudate Atrophy
or Enlarged Lateral Ventricles on Neuroimaging; LEE, Liver Enzyme Elevation;
MD, Movement Disorders (Chorea or Hyperkinetic Movements); NA,
Neuroacanthocytosis; Orof., Orofacial Dyskinesia; PSY, Psychiatric Symptoms.
Figure 1. The Number of Chinese NA Cases Reported in the Last Three
Decades. In the most recent decade (2004 to 2013) the number of reported cases
increased dramatically, being about five times the number documented from 1984
to 1993, and seven times the number
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blood, as well as the exclusion of other possible diseases. Previously this
was the standard diagnostic evaluation worldwide (e.g., a Chinese
patient diagnosed with ChAc in Singapore in the 1980s).60 Recently,
however, there have been clear NA cases without acanthocyte
elevation.61
The other forms of NA, such as HDL-2 and PKAN, have not yet
been reported in China. However, as some of the NA cases reported
had an early age of onset (Table 1), it is likely that PKAN was the
correct diagnosis.
With regard to MLS, only one Chinese case has been identified,
indicating that it is probably underdiagnosed. Without specific
molecular testing, an accurate diagnosis for presumed NA cases is
impossible. As an alternative to DNA analyses, chorein detection by
Western blot is an inexpensive method for diagnosing ChAc, and Kell
antigen phenotyping can be performed to diagnose MLS.55,62
In view of the prevalence of NA syndromes in countries such as the
United Kingdom and Germany (approximately 3 in 10 million), the
number of NA patients in China should be at least 400 and appears
to be underestimated. In addition to raising awareness among
Chinese neurologists, the absence of specific molecular tests is the
main diagnostic flaw that needs to be addressed. A Chinese network
of NA collaboration may improve the diagnosis and treatment
for patients affected by this group of incapacitating hyperkinetic
movements.
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